Cargando…

Psychometric Validation of the ViSIO-PRO and ViSIO-ObsRO in Retinitis Pigmentosa and Leber Congenital Amaurosis

INTRODUCTION: Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA) are rare inherited retinal degenerative disorders. The Visual Symptom and Impact Outcomes patient-reported outcome (ViSIO-PRO) and observer-reported outcome (ViSIO-ObsRO) instruments were developed in this population to ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Fischer, M. Dominik, Patalano, Francesco, Naujoks, Christel, Banhazi, Judit, Bouchet, Christine, O’Brien, Paul, Kay, Christine, Green, Jane, Durham, Todd, Bradley, Helena, Williamson, Nicola, Barclay, Melissa, Sims, Joel, Audo, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011359/
https://www.ncbi.nlm.nih.gov/pubmed/36847938
http://dx.doi.org/10.1007/s40123-023-00670-8
_version_ 1784906374340149248
author Fischer, M. Dominik
Patalano, Francesco
Naujoks, Christel
Banhazi, Judit
Bouchet, Christine
O’Brien, Paul
Kay, Christine
Green, Jane
Durham, Todd
Bradley, Helena
Williamson, Nicola
Barclay, Melissa
Sims, Joel
Audo, Isabelle
author_facet Fischer, M. Dominik
Patalano, Francesco
Naujoks, Christel
Banhazi, Judit
Bouchet, Christine
O’Brien, Paul
Kay, Christine
Green, Jane
Durham, Todd
Bradley, Helena
Williamson, Nicola
Barclay, Melissa
Sims, Joel
Audo, Isabelle
author_sort Fischer, M. Dominik
collection PubMed
description INTRODUCTION: Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA) are rare inherited retinal degenerative disorders. The Visual Symptom and Impact Outcomes patient-reported outcome (ViSIO-PRO) and observer-reported outcome (ViSIO-ObsRO) instruments were developed in this population to assess visual function symptoms and impacts on vision-dependent activities of daily living (ADL) and distal health-related quality of life (HRQoL). This study aimed to explore the psychometric properties of the ViSIO-PRO and ViSIO-ObsRO in RP/LCA. METHODS: The 49-item ViSIO-PRO and 27-item ViSIO-ObsRO instruments were completed by 83 adult and adolescent patients and 22 caregivers of child patients aged 3–11 years with RP/LCA, respectively, at baseline and 12–16-day follow-up. Concurrent measures were also administered at baseline. Psychometric analyses assessed item (question) properties, dimensionality, scoring, reliability, validity, and score interpretation. RESULTS: Item responses were mainly evenly distributed across the response scale, and inter-item correlations were mostly moderate to strong (> 0.30) at baseline within hypothesized domains. Item deletion was informed by item properties, qualitative data, and clinical input and supported retention of 35 ViSIO-PRO items and 25 ViSIO-ObsRO items. Confirmatory factor analysis in line with pre-hypothesized domains supported a four-factor model assessing visual function symptoms, mobility, vision-dependent ADL, and distal HRQoL. A bifactor model supported calculation of total scores and four domain scores. Internal consistency was high for domain and total scores (Cronbach’s alpha > 0.70) and test–retest reliability for total scores was strong between baseline and 12–16-day follow-up (intraclass correlation coefficients 0.66–0.98). Convergent validity was supported by strong correlations in a logical pattern with concurrent measures. Mean baseline scores differed significantly between severity groups. Distribution-based methods provided initial insights to guide interpretation of scores. CONCLUSIONS: Findings supported item reduction and established scoring of the instruments. Evidence of reliability and validity as outcome measures in RP/LCA was also reported. Further research is ongoing to explore responsiveness of the ViSIO-PRO and ViSIO-ObsRO instruments and interpretation of change scores. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40123-023-00670-8.
format Online
Article
Text
id pubmed-10011359
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-100113592023-03-15 Psychometric Validation of the ViSIO-PRO and ViSIO-ObsRO in Retinitis Pigmentosa and Leber Congenital Amaurosis Fischer, M. Dominik Patalano, Francesco Naujoks, Christel Banhazi, Judit Bouchet, Christine O’Brien, Paul Kay, Christine Green, Jane Durham, Todd Bradley, Helena Williamson, Nicola Barclay, Melissa Sims, Joel Audo, Isabelle Ophthalmol Ther Original Research INTRODUCTION: Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA) are rare inherited retinal degenerative disorders. The Visual Symptom and Impact Outcomes patient-reported outcome (ViSIO-PRO) and observer-reported outcome (ViSIO-ObsRO) instruments were developed in this population to assess visual function symptoms and impacts on vision-dependent activities of daily living (ADL) and distal health-related quality of life (HRQoL). This study aimed to explore the psychometric properties of the ViSIO-PRO and ViSIO-ObsRO in RP/LCA. METHODS: The 49-item ViSIO-PRO and 27-item ViSIO-ObsRO instruments were completed by 83 adult and adolescent patients and 22 caregivers of child patients aged 3–11 years with RP/LCA, respectively, at baseline and 12–16-day follow-up. Concurrent measures were also administered at baseline. Psychometric analyses assessed item (question) properties, dimensionality, scoring, reliability, validity, and score interpretation. RESULTS: Item responses were mainly evenly distributed across the response scale, and inter-item correlations were mostly moderate to strong (> 0.30) at baseline within hypothesized domains. Item deletion was informed by item properties, qualitative data, and clinical input and supported retention of 35 ViSIO-PRO items and 25 ViSIO-ObsRO items. Confirmatory factor analysis in line with pre-hypothesized domains supported a four-factor model assessing visual function symptoms, mobility, vision-dependent ADL, and distal HRQoL. A bifactor model supported calculation of total scores and four domain scores. Internal consistency was high for domain and total scores (Cronbach’s alpha > 0.70) and test–retest reliability for total scores was strong between baseline and 12–16-day follow-up (intraclass correlation coefficients 0.66–0.98). Convergent validity was supported by strong correlations in a logical pattern with concurrent measures. Mean baseline scores differed significantly between severity groups. Distribution-based methods provided initial insights to guide interpretation of scores. CONCLUSIONS: Findings supported item reduction and established scoring of the instruments. Evidence of reliability and validity as outcome measures in RP/LCA was also reported. Further research is ongoing to explore responsiveness of the ViSIO-PRO and ViSIO-ObsRO instruments and interpretation of change scores. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40123-023-00670-8. Springer Healthcare 2023-02-27 2023-04 /pmc/articles/PMC10011359/ /pubmed/36847938 http://dx.doi.org/10.1007/s40123-023-00670-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Fischer, M. Dominik
Patalano, Francesco
Naujoks, Christel
Banhazi, Judit
Bouchet, Christine
O’Brien, Paul
Kay, Christine
Green, Jane
Durham, Todd
Bradley, Helena
Williamson, Nicola
Barclay, Melissa
Sims, Joel
Audo, Isabelle
Psychometric Validation of the ViSIO-PRO and ViSIO-ObsRO in Retinitis Pigmentosa and Leber Congenital Amaurosis
title Psychometric Validation of the ViSIO-PRO and ViSIO-ObsRO in Retinitis Pigmentosa and Leber Congenital Amaurosis
title_full Psychometric Validation of the ViSIO-PRO and ViSIO-ObsRO in Retinitis Pigmentosa and Leber Congenital Amaurosis
title_fullStr Psychometric Validation of the ViSIO-PRO and ViSIO-ObsRO in Retinitis Pigmentosa and Leber Congenital Amaurosis
title_full_unstemmed Psychometric Validation of the ViSIO-PRO and ViSIO-ObsRO in Retinitis Pigmentosa and Leber Congenital Amaurosis
title_short Psychometric Validation of the ViSIO-PRO and ViSIO-ObsRO in Retinitis Pigmentosa and Leber Congenital Amaurosis
title_sort psychometric validation of the visio-pro and visio-obsro in retinitis pigmentosa and leber congenital amaurosis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011359/
https://www.ncbi.nlm.nih.gov/pubmed/36847938
http://dx.doi.org/10.1007/s40123-023-00670-8
work_keys_str_mv AT fischermdominik psychometricvalidationofthevisioproandvisioobsroinretinitispigmentosaandlebercongenitalamaurosis
AT patalanofrancesco psychometricvalidationofthevisioproandvisioobsroinretinitispigmentosaandlebercongenitalamaurosis
AT naujokschristel psychometricvalidationofthevisioproandvisioobsroinretinitispigmentosaandlebercongenitalamaurosis
AT banhazijudit psychometricvalidationofthevisioproandvisioobsroinretinitispigmentosaandlebercongenitalamaurosis
AT bouchetchristine psychometricvalidationofthevisioproandvisioobsroinretinitispigmentosaandlebercongenitalamaurosis
AT obrienpaul psychometricvalidationofthevisioproandvisioobsroinretinitispigmentosaandlebercongenitalamaurosis
AT kaychristine psychometricvalidationofthevisioproandvisioobsroinretinitispigmentosaandlebercongenitalamaurosis
AT greenjane psychometricvalidationofthevisioproandvisioobsroinretinitispigmentosaandlebercongenitalamaurosis
AT durhamtodd psychometricvalidationofthevisioproandvisioobsroinretinitispigmentosaandlebercongenitalamaurosis
AT bradleyhelena psychometricvalidationofthevisioproandvisioobsroinretinitispigmentosaandlebercongenitalamaurosis
AT williamsonnicola psychometricvalidationofthevisioproandvisioobsroinretinitispigmentosaandlebercongenitalamaurosis
AT barclaymelissa psychometricvalidationofthevisioproandvisioobsroinretinitispigmentosaandlebercongenitalamaurosis
AT simsjoel psychometricvalidationofthevisioproandvisioobsroinretinitispigmentosaandlebercongenitalamaurosis
AT audoisabelle psychometricvalidationofthevisioproandvisioobsroinretinitispigmentosaandlebercongenitalamaurosis